DIVP vs. IDNA ETF Comparison
Comparison of Cullen Enhanced Equity Income ETF (DIVP) to iShares Genomics Immunology and Healthcare ETF (IDNA)
DIVP
Cullen Enhanced Equity Income ETF
DIVP Description
DIVP invests in large- and mid-cap value stocks that generally have higher dividend yield than the average of the funds US benchmark. The fund identifies value stocks that have low price-to-earnings ratio with above-average earnings and dividend growth potential. Companies are screened using fundamental research. The fund may invest up to 30% in non-US companies in the form of ADRs. While the portfolio is not rebalanced systematically, weighting is roughly equal to avoid overweighting of individual securities. To generate additional income, the fund selectively writes covered call options with a target range of between 25-40%. However, the covered call overlay limits participation in potential gains if shares increase in value. The adviser may sell stocks that are no longer viewed as attractive based on growth potential, dividend yield, or price. As an actively managed ETF, the fund manager has full discretion to make buy, hold, or sell decisions at any time.
Grade (RS Rating)
Last Trade
$26.72
Average Daily Volume
1,720
10
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.Grade (RS Rating)
Last Trade
$24.56
Average Daily Volume
29,136
33
Performance
| Period | DIVP | IDNA |
|---|---|---|
| 30 Days | 2.17% | -1.37% |
| 60 Days | 4.02% | -3.08% |
| 90 Days | 8.32% | 6.23% |
| 12 Months | 22.09% |
1 Overlapping Holdings
| Symbol | Grade | Weight in DIVP | Weight in IDNA | Overlap | |
|---|---|---|---|---|---|
| MRK | F | 3.56% | 3.47% | 3.47% |
DIVP Underweight 32 Positions Relative to IDNA
| Symbol | Grade | Weight | |
|---|---|---|---|
| GILD | B | -5.15% | |
| EXEL | C | -4.81% | |
| INCY | C | -4.42% | |
| RVMD | C | -4.36% | |
| REGN | D | -4.16% | |
| SRPT | F | -4.06% | |
| ACLX | C | -3.78% | |
| TWST | D | -2.94% | |
| GERN | D | -2.49% | |
| SWTX | F | -2.38% | |
| IOVA | F | -2.32% | |
| BEAM | F | -2.16% | |
| LGND | D | -1.96% | |
| NVAX | D | -1.82% | |
| MRNA | F | -1.7% | |
| BCRX | D | -1.68% | |
| DVAX | D | -1.58% | |
| NRIX | D | -1.48% | |
| BPMC | F | -1.37% | |
| CRSP | F | -0.94% | |
| RCUS | D | -0.83% | |
| VIR | F | -0.73% | |
| IBRX | F | -0.67% | |
| ARCT | D | -0.6% | |
| FDMT | F | -0.53% | |
| NTLA | F | -0.49% | |
| OABI | F | -0.45% | |
| EDIT | F | -0.32% | |
| XNCR | D | -0.31% | |
| DNA | F | -0.3% | |
| QURE | F | -0.27% | |
| MGNX | F | -0.2% |
DIVP: Top Represented Industries & Keywords
IDNA: Top Represented Industries & Keywords
Compare ETFs
